Neurological Institute Outcomes
Surgical Quality Improvement
Brain Tumor Surgery Outcomes
Brain Tumor Surgery ACS NSQIP Outcomes
January 1, 2022 – December 31, 2022
The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s overall brain tumor surgery ACS NSQIP performance benchmarked against 222 participating sites.
| Brain Tumor (222 Sites) | N | Observed | Expected |
|---|---|---|---|
| 30 Day Morbidity | 265 | 6.42% | 8.55% |
| Pneumonia | 264 | 1.14% | 2.43% |
| Unplanned Intubation | 263 | 2.28% | 1.87% |
| Ventilator > 48 Hours | 262 | 1.53% | 1.81% |
| Deep Vein Thrombosis (DVT) / Pulmonary Embolus | 265 | 4.15% | 3.57% |
| Renal Failure | 265 | 0.38% | 0.50% |
| Urinary Tract Infection (UTI) | 265 | 0.38% | 1.23% |
| Surgical Site Infection (SSI) | 265 | 2.26% | 2.09% |
| Sepsis | 265 | 1.89% | 0.99% |
| Unplanned Reoperation | 265 | 3.40% | 4.67% |
| Length of Stay | 237 | 15.19% | 22.03% |
| Unplanned Readmission | 265 | 9.06% | 9.48% |
American College of Surgeons National Surgical Quality Improvement Program, 2023.
ACS NSQIP® Semiannual Report July 3, 2023, Chicago: American College of Surgeons.
